Pharma major Lupin announced that it has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest...
Drug firm Torrent Pharmaceuticals is recalling 14 lots of tablets used for treatment of high blood pressure and heart failure from the US market due to...
Pharma company Jubilant Life Sciences has earmarked ₹550 crore for capital expenditure (capex) in the current financial year, a top company official said. It is also...
The US Food and Drug Administration (FDA) has approved the application of pharma major Strides’ arm to market two generic drugs for therapy in North America,...
Pharma major Lupin announced that it has received final approval for its Hydrocortisone Butyrate Lotion, 0.1% from the United States Food and Drug Administration (FDA) to...
Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food and Drug Administration (FDA). CEQUA...
Drug firm GlaxoSmithKline Pharmaceuticals today said it has decided to concentrate on 20 key brands to drive growth going forward. “In keeping with our global approach...
Hospital Planning & Infrastructure (H.P.I.) Summit takes immense pleasure in announcing the next summit which is going to be held in Ahmedabad on 24th of August...
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, today announced that it has entered into a collaboration with leading, home-grown private equity firm True North...
Cipla Limited (Cipla) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Atazanavir Caps 100 mg, 150 mg, 200...
Net profit of Alkem Laboratories rose 15.49% to Rs 129.49 crore in the quarter ended June 2018 as against Rs 112.12 crore during the previous quarter...
Drugmaker Cadila Healthcare reported a three-fold jump year-on-year (Y-o-Y) in net profit to Rs 460.5 crore in the first quarter ended June due to higher sales...
Cipla USA, Inc., a subsidiary of Cipla Limited, announced that it has secured rights from MSN Laboratories Private Limited to market & distribute Capecitabine 150 mg...
Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, announced its financial results for the first quarter ended June 30 of financial year 2018-19. For the...
Net profit of Bal Pharma rose 229.58% to Rs 2.34 crore in the quarter ended June 2018 as against Rs 0.71 crore during the previous quarter...
Copyright © 2024 Medical Buyer